Tatva Chintan Pharma Chem Ltd
NSE:TATVA

Watchlist Manager
Tatva Chintan Pharma Chem Ltd Logo
Tatva Chintan Pharma Chem Ltd
NSE:TATVA
Watchlist
Price: 843.1 INR 3.71% Market Closed
Market Cap: 19.7B INR
Have any thoughts about
Tatva Chintan Pharma Chem Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

43.7
Current
53.6
Median
13.2
Industry
Lower than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
43.7
=
Enterprise Value
19.6B INR
/
EBITDA
448.1m INR
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
44.7
2-Years Forward
EV/EBITDA
16.9
3-Years Forward
EV/EBITDA
11.6

See Also

Discover More